Tecentriq hit with draft NICE rejection
admin 2nd January 2020 Uncategorised 0The UK watchdog says that the “long-term benefit on overall survival is uncertain”.
More: Tecentriq hit with draft NICE rejection
Source: News
The UK watchdog says that the “long-term benefit on overall survival is uncertain”.
More: Tecentriq hit with draft NICE rejection
Source: News
© 1994 - 2026 B.M. Pharmaceuticals